There is a movement to rethink various aspects of medical research, including clinical trial design and the immune system. This reevaluation is being applied to different areas, such as multiple sclerosis, cancer vaccines, and post-stroke immunosuppression, among others. The specific approaches and focuses of these reexaminations appear to vary widely across different fields and studies.